Open Access Subscription or Fee Access
Nanorobots to Treat Breast Cancer: A Review
Nanorobots are nanoelectromechanical systems (NEMS) defining a new frontier in miniaturization, close to microelectromechanical systems (MEMS) which constitute a multibillion-dollar industry in the present era. NEMS research involves biologically inspired design, fabrication, programming, prototyping, and applications such as biomedical nanotechnology. Nanomedicine can offer impressive resolutions for various life-threatening diseases. Nanotechnology applications in biomedical sciences led to the creation of those materials and devices that can interact with the body with a high degree of specificity at sub cellular levels. Nanorobots are tiny machines that can work as today's machines, but more exactly, the development of this new technology, brings benefits in medicine, industry, and other areas. With the combination of biotechnology, molecular biology in the form of engineered organism and molecular medicine can develop fully self-reliant nanorobots or nanobots. The nanorobotics are an advanced submicron device generally made of bio-nanocomponents considered, as a wonderful vision of medicine in the future. It has a renown future in drug delivery technology target in cancer—the disease that is the leading cause of death among younger for more than 85 years. Nanorobots could carry and deliver large amounts of anti-cancer drugs into cancerous cells without harming healthy cells; reducing the side effects related to current therapies like damage of the conventional chemotherapy. This study gives an overview of the present status of nanorobotics in breast cancer therapy. This study focusses on various approaches which are employed towards cancer treatment using nanorobots and provides an insight into the future scope in this field of study.
- There are currently no refbacks.